Ibrahim Altraif

3.9k total citations
18 papers, 162 citations indexed

About

Ibrahim Altraif is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ibrahim Altraif has authored 18 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Ibrahim Altraif's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Ibrahim Altraif is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Ibrahim Altraif collaborates with scholars based in Saudi Arabia, Canada and United States. Ibrahim Altraif's co-authors include Khalid Alswat, Hamdan S. Alghamdi, Adel Alqutub, Faisal Abaalkhail, Mohammed A. Babatin, Mohamed Al-Moamary, Hamad I. Al‐Ashgar, Abdulrahman Aljumah, Mohammad Saeed and Khaled O. Alsaad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Clinical Gastroenterology and Hepatology.

In The Last Decade

Ibrahim Altraif

18 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim Altraif Saudi Arabia 7 120 109 37 17 13 18 162
Nedim Hadzic United Kingdom 2 276 2.3× 201 1.8× 149 4.0× 29 1.7× 12 0.9× 2 312
Mauricio Orrego United States 5 128 1.1× 111 1.0× 42 1.1× 5 0.3× 6 0.5× 6 184
Eléonora De Martin Italy 7 140 1.2× 107 1.0× 57 1.5× 9 0.5× 2 0.2× 20 165
Sara Campos Portugal 7 44 0.4× 79 0.7× 37 1.0× 9 0.5× 13 1.0× 14 146
Jacfranz J. Guiteau United States 7 118 1.0× 48 0.4× 124 3.4× 11 0.6× 28 2.2× 12 191
C Glaubke Germany 3 285 2.4× 264 2.4× 74 2.0× 50 2.9× 3 0.2× 3 313
E. Borghesio Italy 8 199 1.7× 183 1.7× 17 0.5× 39 2.3× 7 0.5× 14 236
V A Saraswat India 6 58 0.5× 60 0.6× 101 2.7× 3 0.2× 9 0.7× 8 153
Anna Cavazza United Kingdom 4 84 0.7× 86 0.8× 37 1.0× 4 0.2× 9 0.7× 10 114
Kirat Gill United States 3 84 0.7× 69 0.6× 5 0.1× 9 0.5× 13 1.0× 5 117

Countries citing papers authored by Ibrahim Altraif

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Altraif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Altraif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Altraif more than expected).

Fields of papers citing papers by Ibrahim Altraif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Altraif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Altraif. The network helps show where Ibrahim Altraif may publish in the future.

Co-authorship network of co-authors of Ibrahim Altraif

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Altraif. A scholar is included among the top collaborators of Ibrahim Altraif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Altraif. Ibrahim Altraif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Alghamdi, Hamdan S., Haleema Alserehi, Mohammed A. Babatin, et al.. (2024). SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024. Saudi Journal of Gastroenterology. 30(Supp 1). S1–S42. 5 indexed citations
2.
Sanai, Faisal M., et al.. (2022). Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels. Saudi Journal of Gastroenterology. 28(5). 341–347. 2 indexed citations
3.
Alqahtani, Saleh A., et al.. (2022). Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia. Saudi Journal of Gastroenterology. 29(2). 135–140. 3 indexed citations
4.
Altraif, Ibrahim, et al.. (2020). Knowledge and attitude toward organ donation among medical staff and outpatients at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Saudi Journal of Kidney Diseases and Transplantation. 31(6). 1344–1344. 5 indexed citations
5.
Altraif, Ibrahim, et al.. (2019). 305.2: Knowledge and attitude towards organ donation among medical staff and outpatients at KAMC, Riyadh, Saudi Arabia.. Transplantation. 103(11S). S55–S56. 1 indexed citations
6.
Omair, Aamir, et al.. (2018). Attitudes and perceptions towards organ donation in Riyadh. 6(2). 68–68. 5 indexed citations
7.
Sanai, Faisal M., Mohammed A. Babatin, Khalid Alswat, et al.. (2017). Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B. BMC Gastroenterology. 17(1). 101–101. 9 indexed citations
8.
Aljumah, Abdulrahman, Faisal Abaalkhail, Hamad I. Al‐Ashgar, et al.. (2016). Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi Journal of Gastroenterology. 22(4). 269–269. 20 indexed citations
9.
Alghamdi, Mohammed, Hamdan S. Alghamdi, Faisal Abaalkhail, et al.. (2016). SASLT guidelines: Update in treatment of Hepatitis C virus infection. Saudi Journal of Gastroenterology. 22(8). 25–25. 15 indexed citations
10.
Alqutub, Adel, et al.. (2015). SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection. Saudi Journal of Gastroenterology. 21(2). 60–60. 8 indexed citations
11.
Sanai, Faisal M., Mohammed A. Babatin, Khalid Bzeizi, et al.. (2013). Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen–Negative Patients With Chronic Hepatitis. Clinical Gastroenterology and Hepatology. 11(11). 1493–1499.e2. 17 indexed citations
12.
Alghamdi, Hamdan S., et al.. (2012). Endoscopic extraction of vascular embolization coils that have migrated into the biliary tract in a liver transplant recipient. Digestive Endoscopy. 24(6). 462–465. 10 indexed citations
13.
Ismail, Mona, Hamdan S. Alghamdi, Khalid Alswat, et al.. (2012). SASLT practice guidelines: Management of hepatitis C virus infection. Saudi Journal of Gastroenterology. 18(7). 1–1. 6 indexed citations
14.
Ismail, Mona, Hamdan S. Alghamdi, Khalid Alswat, et al.. (2012). SASLT practice guidelines for the management of hepatitis C virus infection: Summary of recommendations. Saudi Journal of Gastroenterology. 18(5). 293–293. 2 indexed citations
15.
Altraif, Ibrahim, et al.. (2010). Fatal Subacute Hepatic Failure in a Patient with AA-Type Amyloidosis: Case Report. Pathology Research International. 2010. 1–4. 3 indexed citations
16.
Altraif, Ibrahim, et al.. (1998). Role of Endoscopic Retrograde Cholangiopancreatography Before and After Laparoscopic Cholecystectomy. Annals of Saudi Medicine. 18(2). 117–119. 4 indexed citations
17.
Al-Moamary, Mohamed & Ibrahim Altraif. (1997). Hepatopulmonary Syndrome Associated with Schistosomal Liver Disease. SHILAP Revista de lepidopterología. 11(5). 449–450. 6 indexed citations
18.
Altraif, Ibrahim, et al.. (1995). Hepatitis C Associated Glomerulonephritis. American Journal of Nephrology. 15(5). 407–410. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026